These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21437437)

  • 41. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
    World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.
    Hu Z; Zhou J; Li Z; Xiang J; Zhang Q; Yan S; Wu J; Zhang M; Wang W; Zheng S
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):206-216. PubMed ID: 28107613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of MELD-based allocation on end-stage renal disease after liver transplantation.
    Sharma P; Schaubel DE; Guidinger MK; Goodrich NP; Ojo AO; Merion RM
    Am J Transplant; 2011 Nov; 11(11):2372-8. PubMed ID: 21883908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.
    Cholankeril G; Li AA; Dennis BB; Gadiparthi C; Kim D; Toll AE; Maliakkal BJ; Satapathy SK; Nair S; Ahmed A
    Sci Rep; 2019 Jun; 9(1):8312. PubMed ID: 31165776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation.
    Hong G; Lee KW; Suh S; Yoo T; Kim H; Park MS; Choi Y; Yi NJ; Suh KS
    J Korean Med Sci; 2013 Aug; 28(8):1207-12. PubMed ID: 23960449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome after liver transplantation in elderly recipients (>65 years) - A single-center retrospective analysis.
    Kollmann D; Maschke S; Rasoul-Rockenschaub S; Baron-Stefaniak J; Hofmann M; Silberhumer G; Györi GP; Soliman T; Berlakovich GA
    Dig Liver Dis; 2018 Oct; 50(10):1049-1055. PubMed ID: 30017655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation.
    Allen AM; Heimbach JK; Larson JJ; Mara KC; Kim WR; Kamath PS; Therneau TM
    Transplantation; 2018 Oct; 102(10):1710-1716. PubMed ID: 29620614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation.
    Machicao VI; Srinivas TR; Hemming AW; Soldevila-Pico C; Firpi RJ; Reed AI; Morelli GJ; Nelson DR; Abdelmalek MF
    Liver Transpl; 2006 May; 12(5):754-61. PubMed ID: 16528716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
    Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG
    Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum sodium and survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Goodrich NP; Merion RM
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases.
    Duan BW; Lu SC; Wang ML; Liu JN; Chi P; Lai W; Wu JS; Guo QL; Lin DD; Liu Y; Zeng DB; Li CY; Meng QH; Ding HG; Chen XY; Liao HY; Ma LQ; Chen Y; Zhang J; Xiang HP; Duan ZP; Li N
    J Surg Res; 2013 Aug; 183(2):936-43. PubMed ID: 23558257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.